Last edition
News about "oncology biosimilars "
Samsung Bioepis achieves positive Phase 1 results for Keytruda biosimilar candidate SB27
The biopharmaceutical company announced that its proposed pembrolizumab biosimilar, SB27, met primary pharmacokinetic endpoints in a global Phase 1 study involving non-small cell lung cancer patients, advancing its oncology biosimilar pipeline.
Oncology Biosimilars | 08/05/2026 | By News Bureau | 144
BioDlink Launches Bevacizumab Biosimilar in Colombia and Pakistan
BioDlink’s bevacizumab injection secures marketing authorization in Colombia and Pakistan following its recent approval in Nigeria.<br />
Oncology Biosimilars | 14/08/2025 | By Dineshwori | 256
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy